-+ 0.00%
-+ 0.00%
-+ 0.00%

Tenax Therapeutics shareholders ratified Cherry Bekaert as independent auditor for 2026

PUBT·06/04/2026 20:11:19
Listen to the news
Tenax Therapeutics shareholders ratified Cherry Bekaert as independent auditor for 2026
  • Tenax Therapeutics held its annual stockholder meeting on June 2, 2026.
  • Stockholders elected the company’s director nominees to the board.
  • Stockholders ratified Cherry Bekaert LLP as independent registered public accounting firm for the year ending Dec. 31, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenax Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-257400), on June 04, 2026, and is solely responsible for the information contained therein.